Last 12 months
Inside the activity.
0 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 13, 2020 Filed Aug 13, 2020 21:18 UTC |
FINNEY ELISHA WDirector
|
SaleCommon Stock | 790 | $190.00 | $150,100.00 |
DisclosureSEC source: 0001209191-20-046635 · doc4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,483 Read SEC document |
| July 16, 2020 Filed Jul 16, 2020 21:40 UTC |
SWINNEY ROBERT SDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $37.00 | $0.00 |
DisclosureSEC source: 0001073398-20-000005 · edgardoc.xml · derivative · entry 4 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2020-07-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These stock options vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| July 16, 2020 Filed Jul 16, 2020 21:40 UTC |
SWINNEY ROBERT SDirector
|
SaleCommon Stock | 300 | $188.46 | $56,538.00 |
DisclosureSEC source: 0001073398-20-000005 · edgardoc.xml · nonDerivative · entry 2 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,282 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2019. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| July 16, 2020 Filed Jul 16, 2020 21:40 UTC |
SWINNEY ROBERT SDirector
|
Exercise / conversionCommon Stock | 1,500 | $37.00 | $55,500.00 |
DisclosureSEC source: 0001073398-20-000005 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 8,800 | $46.53 Strike: $46.53 | $409,464.00 |
DisclosureSEC source: 0001073397-20-000003 · edgardoc.xml · derivative · entry 12 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,295 Underlying: Common Stock · 8,800 shares Expires 2022-02-01 F8 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
GiftCommon Stock | 4,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001073397-20-000003 · edgardoc.xml · nonDerivative · entry 9 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,814 F7 · price: This was a bona fide gift with no payment in consideration Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 1,000 | $198.93 | $198,933.80 |
DisclosureSEC source: 0001073397-20-000003 · edgardoc.xml · nonDerivative · entry 8 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,764 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.30 to $199.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 1,100 | $197.19 | $216,908.78 |
DisclosureSEC source: 0001073397-20-000003 · edgardoc.xml · nonDerivative · entry 7 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,764 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.03 to $197.44, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 1,200 | $196.16 | $235,397.16 |
DisclosureSEC source: 0001073397-20-000003 · edgardoc.xml · nonDerivative · entry 6 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,864 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.88 to $196.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 505 | $194.58 | $98,264.77 |
DisclosureSEC source: 0001073397-20-000003 · edgardoc.xml · nonDerivative · entry 5 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,064 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.06 to $194.93, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 4,995 | $193.29 | $965,505.53 |
DisclosureSEC source: 0001073397-20-000003 · edgardoc.xml · nonDerivative · entry 4 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,569 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.91 to $193.52, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
OtherCommon Stock | 8,800 | $46.53 | $409,464.00 |
DisclosureSEC source: 0001073397-20-000003 · edgardoc.xml · nonDerivative · entry 3 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,564 Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,200 | $46.53 Strike: $46.53 | $55,836.00 |
DisclosureSEC source: 0001073397-20-000003 · edgardoc.xml · derivative · entry 11 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,095 Underlying: Common Stock · 1,200 shares Expires 2022-02-01 F8 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 1,200 | $203.11 | $243,735.60 |
DisclosureSEC source: 0001073397-20-000003 · edgardoc.xml · nonDerivative · entry 2 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,764 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.00 to $203.27, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
OtherCommon Stock | 1,200 | $46.53 | $55,836.00 |
DisclosureSEC source: 0001073397-20-000003 · edgardoc.xml · nonDerivative · entry 1 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,964 Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 23:38 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 9,331 | $46.53 Strike: $46.53 | $434,171.43 |
DisclosureSEC source: 0001073397-20-000002 · edgardoc.xml · derivative · entry 8 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,295 Underlying: Common Stock · 9,331 shares Expires 2022-02-01 F4 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 23:38 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 9,331 | $199.00 | $1,856,869.00 |
DisclosureSEC source: 0001073397-20-000002 · edgardoc.xml · nonDerivative · entry 5 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,764 F3 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 23:38 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
OtherCommon Stock | 9,331 | $46.53 | $434,171.43 |
DisclosureSEC source: 0001073397-20-000002 · edgardoc.xml · nonDerivative · entry 4 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,095 Read SEC document |
| June 02, 2020 Filed Jun 3, 2020 20:59 UTC |
Jain VivekDirector · Chairman and CEO
|
GiftCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000005 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,181 F1 · price: This was a bona fide gift with no payment in consideration Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 23:38 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 4,118 | $46.53 Strike: $46.53 | $191,610.54 |
DisclosureSEC source: 0001073397-20-000002 · edgardoc.xml · derivative · entry 7 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,626 Underlying: Common Stock · 4,118 shares Expires 2022-02-01 F4 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 23:38 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 464 | $201.39 | $93,445.66 |
DisclosureSEC source: 0001073397-20-000002 · edgardoc.xml · nonDerivative · entry 3 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,764 F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $201.11 to $202.01, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 23:38 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 3,654 | $200.15 | $731,350.29 |
DisclosureSEC source: 0001073397-20-000002 · edgardoc.xml · nonDerivative · entry 2 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,228 F1 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.92, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 23:38 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
OtherCommon Stock | 4,118 | $46.53 | $191,610.54 |
DisclosureSEC source: 0001073397-20-000002 · edgardoc.xml · nonDerivative · entry 1 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,882 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:59 UTC |
Jain VivekDirector · Chairman and CEO
|
SaleCommon Stock | 2,768 | $202.52 | $560,572.32 |
DisclosureSEC source: 0001410442-20-000005 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,211 F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $202.50 to $202.73, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:59 UTC |
Jain VivekDirector · Chairman and CEO
|
SaleCommon Stock | 12,232 | $204.18 | $2,497,479.61 |
DisclosureSEC source: 0001410442-20-000005 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,979 F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $204.00 to $204.25, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:51 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 10,113 | $46.53 Strike: $46.53 | $470,557.89 |
DisclosureSEC source: 0001073397-20-000001 · edgardoc.xml · derivative · entry 7 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,744 Underlying: Common Stock · 10,113 shares Expires 2022-02-01 F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:51 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
OtherNon-Qualified Stock Option (right to buy) · Derivative | 6,438 | $43.62 Strike: $43.62 | $280,825.56 |
DisclosureSEC source: 0001073397-20-000001 · edgardoc.xml · derivative · entry 6 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,438 shares Expires 2021-07-20 F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:51 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
OtherCommon Stock | 10,113 | $46.53 | $470,557.89 |
DisclosureSEC source: 0001073397-20-000001 · edgardoc.xml · nonDerivative · entry 4 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,764 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:51 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 3 | $198.09 | $594.27 |
DisclosureSEC source: 0001073397-20-000001 · edgardoc.xml · nonDerivative · entry 3 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,651 F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:51 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 16,548 | $197.37 | $3,266,143.30 |
DisclosureSEC source: 0001073397-20-000001 · edgardoc.xml · nonDerivative · entry 2 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,654 F1 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $197.00 to $197.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:51 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
OtherCommon Stock | 6,438 | $43.62 | $280,825.56 |
DisclosureSEC source: 0001073397-20-000001 · edgardoc.xml · nonDerivative · entry 1 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,202 Read SEC document |
| May 21, 2020 Filed Jun 3, 2020 20:59 UTC |
Jain VivekDirector · Chairman and CEO
|
GiftCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-20-000005 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,211 F1 · price: This was a bona fide gift with no payment in consideration Read SEC document |
| May 13, 2020 Filed May 14, 2020 19:59 UTC |
Hoffmeister David FDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,438 | $0.00 Strike: $181.99 | $0.00 |
DisclosureSEC source: 0001209191-20-029138 · doc4.xml · derivative · entry 4 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,438 Underlying: Common Stock · 1,438 shares Expires 2030-05-13 Read SEC document |
| May 13, 2020 Filed May 14, 2020 19:59 UTC |
Hoffmeister David FDirector
|
GrantCommon Stock · Derivative | 468 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029138 · doc4.xml · derivative · entry 3 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468 Underlying: Common Stock · 468 shares Expires 2021-05-13 F4 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 13, 2020 Filed May 14, 2020 19:59 UTC |
Hoffmeister David FDirector
|
Exercise / conversionCommon Stock · Derivative | 378 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029138 · doc4.xml · derivative · entry 2 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 378 shares Expires 2020-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 13, 2020 Filed May 14, 2020 19:59 UTC |
Hoffmeister David FDirector
|
Exercise / conversionCommon Stock | 378 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029138 · doc4.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 693 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2020 Filed May 14, 2020 19:50 UTC |
FINNEY ELISHA WDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,438 | $0.00 Strike: $181.99 | $0.00 |
DisclosureSEC source: 0001209191-20-029137 · doc4.xml · derivative · entry 4 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,438 Underlying: Common Stock · 1,438 shares Expires 2030-05-13 Read SEC document |
| May 13, 2020 Filed May 14, 2020 19:50 UTC |
FINNEY ELISHA WDirector
|
GrantCommon Stock · Derivative | 468 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029137 · doc4.xml · derivative · entry 3 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468 Underlying: Common Stock · 468 shares Expires 2021-05-13 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 13, 2020 Filed May 14, 2020 19:50 UTC |
FINNEY ELISHA WDirector
|
Exercise / conversionCommon Stock · Derivative | 378 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029137 · doc4.xml · derivative · entry 2 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 378 shares Expires 2020-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 13, 2020 Filed May 14, 2020 19:50 UTC |
FINNEY ELISHA WDirector
|
Exercise / conversionCommon Stock | 378 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029137 · doc4.xml · nonDerivative · entry 1 FINNEY ELISHA W · CIK 0001217439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2020 Filed May 14, 2020 16:54 UTC |
Abbey DonaldDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,438 | $0.00 Strike: $181.99 | $0.00 |
DisclosureSEC source: 0001209191-20-029075 · doc4.xml · derivative · entry 4 Abbey Donald · CIK 0001534342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,438 Underlying: Common Stock · 1,438 shares Expires 2030-05-13 Read SEC document |
| May 13, 2020 Filed May 14, 2020 16:54 UTC |
Abbey DonaldDirector
|
GrantCommon Stock · Derivative | 468 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029075 · doc4.xml · derivative · entry 3 Abbey Donald · CIK 0001534342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468 Underlying: Common Stock · 468 shares Expires 2021-05-13 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 13, 2020 Filed May 14, 2020 16:54 UTC |
Abbey DonaldDirector
|
Exercise / conversionCommon Sock · Derivative | 378 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029075 · doc4.xml · derivative · entry 2 Abbey Donald · CIK 0001534342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 378 shares Expires 2020-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 13, 2020 Filed May 14, 2020 16:54 UTC |
Abbey DonaldDirector
|
Exercise / conversionCommon Stock | 378 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029075 · doc4.xml · nonDerivative · entry 1 Abbey Donald · CIK 0001534342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 693 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2020 Filed May 14, 2020 16:18 UTC |
SWINNEY ROBERT SDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,438 | $0.00 Strike: $181.99 | $0.00 |
DisclosureSEC source: 0001073398-20-000004 · edgardoc.xml · derivative · entry 5 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,438 Underlying: Common Stock · 1,438 shares Expires 2030-05-13 Read SEC document |
| May 13, 2020 Filed May 14, 2020 16:18 UTC |
SWINNEY ROBERT SDirector
|
GrantCommon Stock · Derivative | 468 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001073398-20-000004 · edgardoc.xml · derivative · entry 4 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468 Underlying: Common Stock · 468 shares Expires 2021-05-13 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 13, 2020 Filed May 14, 2020 16:18 UTC |
SWINNEY ROBERT SDirector
|
Exercise / conversionCommon Stock · Derivative | 378 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001073398-20-000004 · edgardoc.xml · derivative · entry 3 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 378 shares Expires 2020-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 13, 2020 Filed May 14, 2020 16:18 UTC |
SWINNEY ROBERT SDirector
|
Exercise / conversionCommon Stock | 378 | $0.00 | $0.00 |
DisclosureSEC source: 0001073398-20-000004 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2020 Filed May 14, 2020 16:25 UTC |
Greenberg David C.Director
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,438 | $0.00 Strike: $181.99 | $0.00 |
DisclosureSEC source: 0001645866-20-000001 · edgardoc.xml · derivative · entry 5 Greenberg David C. · CIK 0001645866 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,438 Underlying: Common Stock · 1,438 shares Expires 2030-05-13 Read SEC document |
| May 13, 2020 Filed May 14, 2020 16:25 UTC |
Greenberg David C.Director
|
GrantCommon Stock · Derivative | 468 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001645866-20-000001 · edgardoc.xml · derivative · entry 4 Greenberg David C. · CIK 0001645866 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468 Underlying: Common Stock · 468 shares Expires 2021-05-13 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.